Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Noncoding RNAs as effective markers in cancer-care management

Nature Medicine volume 23, pages 1122–1123 (2017)Cite this article

Subjects

Two recent studies show that 'silent' variants can modulate regulatory circuits, including those in noncoding RNAs, affecting cancer predisposition and drug sensitivity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Single-nucleotide variants in noncoding RNAs influence cancer susceptibility and drug sensitivity.

References

  1. Simon, R. & Roychowdhury, S. Nat. Rev. Drug Discov. 12, 358–369 (2013).

    Article  CAS  Google Scholar 

  2. Pickrell, J.K. Am. J. Hum. Genet. 94, 559–573 (2014).

    Article  CAS  Google Scholar 

  3. Tan, D.S.W. et al. Nat. Med. 23, 1167–1175 (2017).

    Article  CAS  Google Scholar 

  4. Bal, E. et al. Nat. Med. 23, 1226–1233 (2017).

    Article  CAS  Google Scholar 

  5. Heid, H. et al. Exp. Cell Res. 279, 177–187 (2002).

    Article  CAS  Google Scholar 

  6. Chi, A.C., Day, T.A. & Neville, B.W. CA Cancer J. Clin. 65, 401–421 (2015).

    Article  Google Scholar 

  7. Rivera, C. Int. J. Clin. Exp. Pathol. 8, 11884–11894 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Baron, A.T. et al. Cancer Epidemiol. Biomarkers Prev. 12, 103–113 (2003).

    CAS  PubMed  Google Scholar 

  9. Zampino, M.G. et al. Cancer Chemother. Pharmacol. 63, 139–148 (2008).

    Article  CAS  Google Scholar 

  10. Huarte, M. Nat. Med. 21, 1253–1261 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

M.H. and I.R. are supported by the European Research Council Starting Grant 281877 and the Spanish Ministry of Science Grant BFU2014-58027-R.

Author information

Authors and Affiliations

  1. Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, Spain

    Ivan Raimondi & Maite Huarte

  2. Institute of Health Research of Navarra (IdiSNA), Pamplona, Spain

    Ivan Raimondi & Maite Huarte

Authors
  1. Ivan Raimondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maite Huarte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maite Huarte.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raimondi, I., Huarte, M. Noncoding RNAs as effective markers in cancer-care management. Nat Med 23, 1122–1123 (2017). https://doi.org/10.1038/nm.4423

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4423

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing